GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx is well-represented at this year’s largest fall genetics conferences and will be delivering presentations across a variety of medical specialties including whole exome sequencing and hereditary cancer testing.
At the 35th National Society of Genetic Counselors (NSGC) Annual Education Conference in Seattle, Washington, GeneDx will be actively participating in a pre-conference symposium, hosting a sponsored lunch session and presenting 22 poster presentations. The pre-conference symposium will dive into the personal and professional growth opportunities available to genetic counselors and the sponsored lunch session will cover updates to variant classification and prenatal whole exome sequencing. For a complete list of GeneDx’s events at NSGC 2016, you can visit our website at www.genedx.com/NSGC2016, or if attending, you can visit us at booth #803 at the 2016 NSGC conference to learn more.
At the American Society of Human Genetics (ASHG) Annual meeting in Vancouver, Canada, GeneDx will be presenting a platform presentation on POLG related disorders and 13 poster presentations. Six of the GeneDx poster presentations have been selected as Reviewer’s Choice which are awarded to the highest scoring 10% of poster abstracts accepted by ASHG. The poster presentations will cover a breadth of topics including epilepsy disorders, peripheral neuropathy, and rare disorders. For a complete list of GeneDx’s presentations at ASHG 2016, please visit our website at www.genedx.com/ASHG2016, or if attending, you can visit us at booth #633 to learn more.
To coincide with these two fall conferences, GeneDx is excited to announce that they have updated their entire cardiology genetics product line to include both newly published clinically-relevant genes to our panels as well as deletion and duplication testing for all testing indications. To learn more about these updates, please visit our website at www.genedx.com/cardiology. In addition, GeneDx is also pleased to announce the official launch of XomeDxPrenatal, the newest addition to our world renowned XomeDx product line. XomeDxPrenatal is an expedited whole exome sequencing (WES) service specifically designed for use in ongoing pregnancies. Learn more at www.genedx.com/xomedx.
“We are thrilled to once again have the opportunity to be so actively involved in the annual NSGC and ASHG conferences. It truly speaks to the hard work of our entire GeneDx team that we are able to be so well-represented at these conferences,” said Sherri Bale, Ph.D., FACMG, Managing Director, GeneDx and a Founding Member of the American College of Medical Genetics. “We are also excited to have an opportunity to speak with our clients during these meetings about our recently updated cardiology test menu and newly launched XomeDxPrenatal test.”
To learn more about our GeneDx’s complete list of testing options, please visit our website www.genedx.com or email us at firstname.lastname@example.org. Follow us on twitter @GeneDx and become a fan on Facebook @GeneDxLab to get real-time updates from us.
GeneDx is a world leader in Genomics with an acknowledged expertise in rare and ultra rare genetic disorders, as well as one of the broadest menus of sequencing services available among commercial laboratories. GeneDx provides testing to patients and their families in more than 55 countries. GeneDx is a business unit of BioReference Laboratories. To learn more, please visit www.genedx.com.